用最少标注实现小鼠肺肿瘤精准分割，助力新药疗效评估

In drug discovery, accurate lung tumor segmentation is an important step for assessing tumor size and its progression using \textit{in-vivo} imaging such as MRI. While deep learning models have been developed to automate this process, the focus has predominantly been on human subjects, neglecting the pivotal role of animal models in pre-clinical drug development. In this work, we focus on optimizing lung tumor segmentation in mice. First, we demonstrate that the nnU-Net model outperforms the U-Net, U-Net3+, and DeepMeta models. Most importantly, we achieve better results with nnU-Net 3D models than 2D models, indicating the importance of spatial context for segmentation tasks in MRI mice scans. This study demonstrates the importance of 3D input over 2D input images for lung tumor segmentation in MRI scans. Finally, we outperform the prior state-of-the-art approach that involves the combined segmentation of lungs and tumors within the lungs. Our work achieves comparable results using only lung tumor annotations requiring fewer annotations, saving time and annotation efforts. This work (https://anonymous.4open.science/r/lung-tumour-mice-mri-64BB) is an important step in automating pre-clinical animal studies to quantify the efficacy of experimental drugs, particularly in assessing tumor changes.